Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1964 9
1965 4
1966 11
1967 10
1968 10
1969 4
1970 3
1972 1
1973 1
1975 2
1976 1
1977 1
1978 1
1979 2
1980 1
1981 1
1982 4
1983 4
1984 1
1986 4
1987 3
1988 2
1989 7
1990 10
1991 17
1992 10
1993 4
1994 10
1995 3
1996 8
1997 7
1998 7
1999 7
2000 10
2001 17
2002 11
2003 11
2004 12
2005 13
2006 20
2007 7
2008 13
2009 10
2010 19
2011 17
2012 18
2013 19
2014 20
2015 23
2016 20
2017 23
2018 16
2019 18
2020 30
2021 27
2022 18
2023 18
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Results by year

Filters applied: . Clear all
Page 1
Posttreatment Imaging Surveillance.
Farina D, Zorza I, Golemi S, Lombardi D, Borghesi A, Maroldi R, Ravanelli M. Farina D, et al. Among authors: lombardi d. Adv Otorhinolaryngol. 2020;84:218-230. doi: 10.1159/000457941. Epub 2020 Jul 30. Adv Otorhinolaryngol. 2020. PMID: 32731227 Review.
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.
Sims MD, Khanna S, Feuerstadt P, Louie TJ, Kelly CR, Huang ES, Hohmann EL, Wang EEL, Oneto C, Cohen SH, Berenson CS, Korman L, Lee C, Lashner B, Kraft CS, Ramesh M, Silverman M, Pardi DS, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L; ECOSPOR IV Investigators. Sims MD, et al. Among authors: lombardi da. JAMA Netw Open. 2023 Feb 1;6(2):e2255758. doi: 10.1001/jamanetworkopen.2022.55758. JAMA Netw Open. 2023. PMID: 36780159 Free PMC article. Clinical Trial.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: lombardi d. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Paranasal sinus cancer.
Bossi P, Farina D, Gatta G, Lombardi D, Nicolai P, Orlandi E. Bossi P, et al. Among authors: lombardi d. Crit Rev Oncol Hematol. 2016 Feb;98:45-61. doi: 10.1016/j.critrevonc.2015.09.009. Epub 2015 Oct 19. Crit Rev Oncol Hematol. 2016. PMID: 26520459 Review.
Crivellari D, Toffoli G, Lombardi D, Berretta M, Sorio R, Magri MD, Spazzapan S, Scuderi C, Veronesi A. Crivellari D, et al. Among authors: lombardi d. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S73-4. doi: 10.1177/030089160208800122. Tumori. 2002. PMID: 11989932 No abstract available.
Current management and future challenges in salivary glands cancer.
Locati LD, Ferrarotto R, Licitra L, Benazzo M, Preda L, Farina D, Gatta G, Lombardi D, Nicolai P, Vander Poorten V, Chua MLK, Vischioni B, Sanguineti G, Morbini P, Fonseca I, Sozzi D, Merlotti A, Orlandi E. Locati LD, et al. Among authors: lombardi d. Front Oncol. 2023 Sep 19;13:1264287. doi: 10.3389/fonc.2023.1264287. eCollection 2023. Front Oncol. 2023. PMID: 37795454 Free PMC article. Review.
Surgical treatment of salivary malignant tumors.
Lombardi D, McGurk M, Vander Poorten V, Guzzo M, Accorona R, Rampinelli V, Nicolai P. Lombardi D, et al. Oral Oncol. 2017 Feb;65:102-113. doi: 10.1016/j.oraloncology.2016.12.007. Epub 2016 Dec 22. Oral Oncol. 2017. PMID: 28017651 Review.
Advances in occupational traumatic injury research.
Lombardi DA. Lombardi DA. Scand J Work Environ Health. 2017 May 1;43(3):191-195. doi: 10.5271/sjweh.3640. Epub 2017 Apr 3. Scand J Work Environ Health. 2017. PMID: 28368548 Free article. No abstract available.
Mucosal melanoma of the head and neck.
Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, Gogas H, Lombardi D, Maroldi R, Nicolai P, Ravanelli M, Vanella V. Ascierto PA, et al. Among authors: lombardi d. Crit Rev Oncol Hematol. 2017 Apr;112:136-152. doi: 10.1016/j.critrevonc.2017.01.019. Epub 2017 Feb 13. Crit Rev Oncol Hematol. 2017. PMID: 28325255 Review.
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.
Berenson CS, Lashner B, Korman LY, Hohmann E, Deshpande A, Louie TJ, Sims M, Pardi D, Kraft CS, Wang EEL, Cohen SH, Feuerstadt P, Oneto C, Misra B, Pullman J, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Lee CH. Berenson CS, et al. Among authors: lombardi da. Clin Infect Dis. 2023 Nov 30;77(11):1504-1510. doi: 10.1093/cid/ciad448. Clin Infect Dis. 2023. PMID: 37539715 Free PMC article. Clinical Trial.
529 results